Cargando…
Beneficial Immune Regulation by Biological Response Modifier Glucans in COVID-19 and Their Envisaged Potentials in the Management of Sepsis
Sepsis is a life-threatening condition caused by an abnormal immune response induced by infection with no approved or specific therapeutic options. We present our perspectives for the therapeutic management of sepsis through a four-way approach: (1) infection control through immune enhancement; (2)...
Autores principales: | Preethy, Senthilkumar, Raghavan, Kadalraja, Dedeepiya, Vidyasagar Devaprasad, Surya Prakash, Vaddi, Ikewaki, Nobunao, Ikeue, Yasunori, Nagataki, Mitsuru, Iwasaki, Masaru, Senthilkumar, Rajappa, Abraham, Samuel J. K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272021/ https://www.ncbi.nlm.nih.gov/pubmed/35833122 http://dx.doi.org/10.3389/fimmu.2022.870632 |
Ejemplares similares
-
Beneficial effects of novel aureobasidium pullulans strains produced beta-1,3-1,6 glucans on interleukin-6 and D-dimer levels in COVID-19 patients; results of a randomized multiple-arm pilot clinical study
por: Raghavan, Kadalraja, et al.
Publicado: (2022) -
Beneficial immune-modulatory effects of the N-163 strain of Aureobasidium pullulans-produced 1,3-1,6 Beta glucans in Duchenne muscular dystrophy: Results of an open-label, prospective, exploratory case-control clinical study
por: Raghavan, Kadalraja, et al.
Publicado: (2023) -
Corrigendum to “Beneficial immune-modulatory effects of the N-163 strain of Aureobasidium pullulans-produced 1,3-1,6 Beta glucans in Duchenne muscular dystrophy: Results of an open-label, prospective, exploratory case-control clinical study” [IBRO Neurosci. Rep. 15 (2023), pp. 90–99]
por: Raghavan, Kadalraja, et al.
Publicado: (2023) -
Improvement of behavioural pattern and alpha-synuclein levels in autism spectrum disorder after consumption of a beta-glucan food supplement in a randomised, parallel-group pilot clinical study
por: Raghavan, Kadalraja, et al.
Publicado: (2022) -
Two unique biological response-modifier glucans beneficially regulating gut microbiota and faecal metabolome in a non-alcoholic steatohepatitis animal model, with potential applications in human health and disease
por: Preethy, Senthilkumar, et al.
Publicado: (2022)